RESPONSE AFTER NON-FINAL ACTION - ENTERED
final action
on 05 Nov 2024
Last Applicant/ Owned by
DK-2730 Herlev
DK
Serial Number
79380013 filed on 19th Jul 2023
Registration Number
N/A
Correspondent Address
Andrew M. Smith
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
NORDICPRO-C2
custom design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; custom design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; custom design and development of biochemical, pharmaceutical, and medical assays; custom design and development of biomarkers for use individually or in combination to d Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
custom design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; custom design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; custom design and development of biochemical, pharmaceutical, and medical assays; custom design and development of biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; providing scientific and pharmaceutical research in the field of biomarkers and biomarker discovery; medical and scientific research, namely, identification of predictive and prognostic biomarkers for clinical trials; medical and scientific research, namely, identifying patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services for clinical trials; scientific research in the nature of conducting clinical trials for others; biological research and analysis, namely, analysis of pharmacodynamic data; biological research and analysis, namely, analysis of data relating to biomarkers; development services in the field of diagnostic preparations, equipment and tests; medical and scientific research, namely, conducting clinical testing services for others; providing reagent sample testing and diagnostic services for others for scientific research purposes namely diagnostic testing services; medical research laboratory services; research laboratory services in the fields of medical and pharmaceutical research; advice, information and assistance relating to the foregoing
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
diagnostic biomarker reagents for medical and clinical purposes; diagnostic biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; biomarker assays to identify disease activity; medical diagnostic biomarker assays to quantify disease activity; medical diagnostic biomarker assays to analyse disease activity; diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, disease analysis and quantifying disease activity; medical diagnostic agents; medical diagnostic reagents; clinical diagnostic agents; clinical diagnostic reagents; medical diagnostic test strips for research and diagnostic use for protein fragment detection, disease detection, disease analysis and quantifying disease activity; diagnostic preparations for medical purposes; diagnostic agents for medical use
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79380013
Mark Type
No Service Mark
Attorney Docket Number
No 1478.0002
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 05th Nov 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 05th Nov 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 05th Nov 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 27th May 2024 | REFUSAL PROCESSED BY IB |
| 08th May 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| 08th May 2024 | REFUSAL PROCESSED BY MPU |
| 03rd May 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| 02th May 2024 | NON-FINAL ACTION WRITTEN |
| 25th Mar 2024 | ASSIGNED TO EXAMINER |
| 10th Oct 2023 | APPLICATION FILING RECEIPT MAILED |